Literature DB >> 12176483

Tacrolimus is associated with a lower incidence of cardiovascular complications in liver transplant recipients.

J M Rabkin1, H R Rosen, C L Corless, A J Olyaei.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12176483     DOI： 10.1016/s0041-1345(02)03020-8

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  5 in total

1.  Medical Management of Metabolic Complications of Liver Transplant Recipients.

Authors:  Abbey Barnard; Peter Konyn; Sammy Saab
Journal:  Gastroenterol Hepatol (N Y)       Date:  2016-10

Review 2.  The Role of mTOR Inhibitors in Liver Transplantation: Reviewing the Evidence.

Authors:  Goran B Klintmalm; Björn Nashan
Journal:  J Transplant       Date:  2014-02-25

3.  Posttransplant metabolic syndrome.

Authors:  M Shadab Siddiqui; Richard K Sterling
Journal:  Int J Hepatol       Date:  2012-11-27

4.  Post-operative hypertension, a surrogate marker of the graft function and predictor of survival in living donor liver transplant recipients: A retrospective study.

Authors:  Manish Tandon; Anshuman Singh; Vandana Saluja; Gaurav Dubey; Vijay Kant Pandey; Chandra Kant Pandey; Sunaina Tejpal Karna; Shweta A Singh
Journal:  Indian J Anaesth       Date:  2016-07

Review 5.  Expert consensus on management of metabolic disease in Chinese liver transplant recipients.

Authors:  Tian Shen; Li Zhuang; Xiao-Dong Sun; Xiao-Sheng Qi; Zhi-Hui Wang; Rui-Dong Li; Wen-Xiu Chang; Jia-Yin Yang; Yang Yang; Shu-Sen Zheng; Xiao Xu
Journal:  World J Gastroenterol       Date:  2020-07-21       Impact factor: 5.742
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.